Brain-derived neurotrophic factor is essential for opiate-induced plasticity of noradrenergic neurons
Journal Article
Overview
publication date
has subject area
-
Alcohols - Norepinephrine
-
Amines - Norepinephrine
-
Amines - Norepinephrine
-
Animal Population Groups - Mice, Transgenic
-
Animals
-
Behavior, Animal
-
Biochemical Phenomena - Down-Regulation
-
Biochemical Phenomena - Signal Transduction
-
Biogenic Monoamines - Norepinephrine
-
Biological Factors - Brain-Derived Neurotrophic Factor
-
Catechols - Norepinephrine
-
Cell Physiological Phenomena - Cell Count
-
Cell Physiological Phenomena - Signal Transduction
-
Cells - Neurons
-
Central Nervous System Agents - Narcotics
-
Central Nervous System Agents - Narcotics
-
Chemically-Induced Disorders - Substance Withdrawal Syndrome
-
Colforsin
-
Diagnostic Techniques and Procedures - Cell Count
-
Diagnostic Techniques and Procedures - In Situ Hybridization
-
Diagnostic Techniques and Procedures - In Situ Hybridization
-
Environment and Public Health - Severity of Illness Index
-
Gene Expression Regulation - Down-Regulation
-
Genes, Reporter
-
Genetic Techniques - In Situ Hybridization
-
Genotype
-
Health Care Evaluation Mechanisms - Severity of Illness Index
-
In Vitro Techniques
-
Integrases
-
Investigative Techniques - Cell Count
-
Investigative Techniques - Cell Count
-
Investigative Techniques - In Situ Hybridization
-
Investigative Techniques - In Situ Hybridization
-
Investigative Techniques - Severity of Illness Index
-
Mental Disorders - Substance Withdrawal Syndrome
-
Mesencephalon - Locus Coeruleus
-
Metalloproteins - Tyrosine 3-Monooxygenase
-
Mice
-
Mice - Mice, Transgenic
-
Mice, Mutant Strains
-
Mixed Function Oxygenases - Tyrosine 3-Monooxygenase
-
Mutagenesis - Gene Deletion
-
Mutation - Gene Deletion
-
Nerve Tissue Proteins - Brain-Derived Neurotrophic Factor
-
Nervous System - Neurons
-
Neuronal Plasticity
-
Nucleic Acids, Nucleotides, and Nucleosides - Cyclic AMP
-
Nucleotides, Cyclic - Cyclic AMP
-
Peptides - Brain-Derived Neurotrophic Factor
-
Peptides - Calcium-Calmodulin-Dependent Protein Kinase Type 2
-
Peptides - Calcium-Calmodulin-Dependent Protein Kinases
-
Pharmacological Phenomena - Down-Regulation
-
Physiological Effects of Drugs - Narcotics
-
Pontine Tegmentum - Locus Coeruleus
-
Protein-Serine-Threonine Kinases - Calcium-Calmodulin-Dependent Protein Kinase Type 2
-
Protein-Serine-Threonine Kinases - Calcium-Calmodulin-Dependent Protein Kinases
-
Proteins - Brain-Derived Neurotrophic Factor
-
Proteins - Calcium-Calmodulin-Dependent Protein Kinase Type 2
-
Proteins - Calcium-Calmodulin-Dependent Protein Kinases
-
Purines - Cyclic AMP
-
Receptors, G-Protein-Coupled - Receptors, Opioid, mu
-
Receptors, Neurotransmitter - Receptors, Opioid, mu
-
Receptors, Peptide - Receptors, Opioid, mu
-
Recombination, Genetic
-
Ribonucleotides - Cyclic AMP
-
Sensory System Agents - Narcotics
-
Transgenes
-
Viral Proteins
has restriction
Date in CU Experts
-
September 9, 2013 10:31 AM
Full Author List
-
Akbarian S; Rios M; Liu RJ; Gold SJ; Fong HF; Zeiler S; Coppola V; Tessarollo L; Jones KR; Nestler EJ
author count
citation count
published in
Other Profiles
International Standard Serial Number (ISSN)
Digital Object Identifier (DOI)
Additional Document Info
start page
end page
volume
issue